Join the NC TraCS Comparative Effectiveness Research team and guest expert Timothy Sheahan, PhD, to discuss the phase 2 trial results of molnupiravir, the new potential treatment for COVID-19.
Journal article for this discussion:
Molnupiravir, an Oral Antiviral Treatment for COVID-19 -
https://www.medrxiv.org/content/10.1101/2021.06.17.21258639v1 Discussion Leaders:
Michele Jonsson-Funk, PhD
Associate Professor, Epidemiology
Gillings School of Public Health
Timothy Sheahan, PhD
Assistant Professor, Epidemiology
Gillings School of Public Health
Sara DejenePhD Candidate, Epidemiology
Gillings School of Public Health